Cite
HARVARD Citation
Uslu, S. et al. (n.d.). THU0218 The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the turkbio registry. Annals of the rheumatic diseases. p. 329. [Online].